BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23129749)

  • 1. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations.
    Snow AL; Xiao W; Stinson JR; Lu W; Chaigne-Delalande B; Zheng L; Pittaluga S; Matthews HF; Schmitz R; Jhavar S; Kuchen S; Kardava L; Wang W; Lamborn IT; Jing H; Raffeld M; Moir S; Fleisher TA; Staudt LM; Su HC; Lenardo MJ
    J Exp Med; 2012 Nov; 209(12):2247-61. PubMed ID: 23129749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline CARD11 Mutation in a Patient with Severe Congenital B Cell Lymphocytosis.
    Brohl AS; Stinson JR; Su HC; Badgett T; Jennings CD; Sukumar G; Sindiri S; Wang W; Kardava L; Moir S; Dalgard CL; Moscow JA; Khan J; Snow AL
    J Clin Immunol; 2015 Jan; 35(1):32-46. PubMed ID: 25352053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Characterization of a Germline Mutation in CARD11 From a Chinese Case of B Cell Expansion With NF-κB and T Cell Anergy.
    Zhao P; Meng Q; Huang Y; Zhang L; Luo S; Zhang X; Tan L; Zhou A; Xiong H; He X
    Front Immunol; 2021; 12():676386. PubMed ID: 34557185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Unique Heterozygous
    Desjardins M; Arjunaraja S; Stinson JR; Dorjbal B; Sundaresan J; Niemela J; Raffeld M; Matthews HF; Wang A; Angelus P; Su HC; Mazer BD; Snow AL
    Front Immunol; 2018; 9():2944. PubMed ID: 30619304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel CARD11 germline mutation in a Chinese patient of B cell expansion with NF-κB and T cell anergy (BENTA) and literature review.
    Zhao P; Hu Y; Sun D; Meng Q; Zhang L; Zhang X; Tan L; Zhang Y; Ding Y; He X
    Front Immunol; 2022; 13():943027. PubMed ID: 36203613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease.
    Shields AM; Bauman BM; Hargreaves CE; Pollard AJ; Snow AL; Patel SY
    J Clin Immunol; 2020 Feb; 40(2):406-411. PubMed ID: 31897776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-function mutations in CARD11 promote enhanced aggregation and idiosyncratic signalosome assembly.
    Stinson JR; Dorjbal B; McDaniel DP; David L; Wu H; Snow AL
    Cell Immunol; 2020 Jul; 353():104129. PubMed ID: 32473470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A familial case of B-cell expansion with NF-κB and T-cell anergy caused by a G123D heterozygous missense mutation in the CARD11 gene.
    Takase Y; Tanioka S; Ishimura M; Yoshiura KI; Mori Y; Sakaida E; Funakoshi Y; Moriuchi H
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29941. PubMed ID: 36129242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling.
    Wang Z; Hutcherson SM; Yang C; Jattani RP; Tritapoe JM; Yang YK; Pomerantz JL
    J Biol Chem; 2019 Oct; 294(40):14648-14660. PubMed ID: 31391255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.
    Lenz G; Davis RE; Ngo VN; Lam L; George TC; Wright GW; Dave SS; Zhao H; Xu W; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Chan WC; Staudt LM
    Science; 2008 Mar; 319(5870):1676-9. PubMed ID: 18323416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, Immunological, and Molecular Findings in Four Cases of B Cell Expansion With NF-κB and T Cell Anergy Disease for the First Time From India.
    Gupta M; Aluri J; Desai M; Lokeshwar M; Taur P; Lenardo M; Bergerson J; Dalvi A; Mhatre S; Kulkarni M; Kambli P; Madkaikar M
    Front Immunol; 2018; 9():1049. PubMed ID: 29963038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency.
    Lu HY; Sharma M; Sharma AA; Lacson A; Szpurko A; Luider J; Dharmani-Khan P; Shameli A; Bell PA; Guilcher GMT; Lewis VA; Vasquez MR; Desai S; McGonigle L; Murguia-Favela L; Wright NAM; Sergi C; Wine E; Overall CM; Suresh S; Turvey SE
    J Allergy Clin Immunol; 2021 Dec; 148(6):1559-1574.e13. PubMed ID: 33872653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
    Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
    J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Immunoglobulin Kappa Locus Rearrangement in a Patient with CARD11-Related B Cell Lymphocytosis.
    Ludgate JL; Weeks RJ; Morison IM
    J Clin Immunol; 2021 Nov; 41(8):1943-1945. PubMed ID: 34355353
    [No Abstract]   [Full Text] [Related]  

  • 15. A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival.
    Chan W; Schaffer TB; Pomerantz JL
    Mol Cell Biol; 2013 Jan; 33(2):429-43. PubMed ID: 23149938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain.
    Lamason RL; McCully RR; Lew SM; Pomerantz JL
    Biochemistry; 2010 Sep; 49(38):8240-50. PubMed ID: 20799731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline hypomorphic CARD11 mutations in severe atopic disease.
    Ma CA; Stinson JR; Zhang Y; Abbott JK; Weinreich MA; Hauk PJ; Reynolds PR; Lyons JJ; Nelson CG; Ruffo E; Dorjbal B; Glauzy S; Yamakawa N; Arjunaraja S; Voss K; Stoddard J; Niemela J; Zhang Y; Rosenzweig SD; McElwee JJ; DiMaggio T; Matthews HF; Jones N; Stone KD; Palma A; Oleastro M; Prieto E; Bernasconi AR; Dubra G; Danielian S; Zaiat J; Marti MA; Kim B; Cooper MA; Romberg N; Meffre E; Gelfand EW; Snow AL; Milner JD
    Nat Genet; 2017 Aug; 49(8):1192-1201. PubMed ID: 28628108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation.
    Watt SA; Purdie KJ; den Breems NY; Dimon M; Arron ST; McHugh AT; Xue DJ; Dayal JH; Proby CM; Harwood CA; Leigh IM; South AP
    Am J Pathol; 2015 Sep; 185(9):2354-63. PubMed ID: 26212909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma.
    Bu R; Bavi P; Abubaker J; Jehan Z; Al-Haqawi W; Ajarim D; Al-Dayel F; Uddin S; Al-Kuraya KS
    Leuk Lymphoma; 2012 Oct; 53(10):1971-7. PubMed ID: 22397314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.
    Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL
    J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.